ANTIPLASMODIAL ACTIVITY AND MECHANISMS OF ACTION OF EURYCOMA LONGIFOLIA JACK ROOT ISOLATED COMPOUNDS

Mahardika Agus Wijayanti1, Eti Nurwening Sholikhah2, Mustofa2

Authors

  • ojsadmin ojsadmin

Keywords:

Eurycoma longifolia Jack root, in vitro antiplasmodial activity, selectivity index, protease inhibitor, HPIA

Abstract

Eurycoma longifolia Jack is a medicinal plant had been traditionally used as an antimalarial agent in Indonesia. Antiplasmodial activity and action mechanisms of E. longifolia Jack root isolated compounds have not previously been evaluated. In this study we aimed to identify the activity and mechanisms of action of E. longifolia Jack against Plasmodium falciparum to determine its potential as an antimalarial agent. Five different isolated compounds of the ethyl acetate soluble fraction derived from E. longifolia Jack root methanol extract were tested. The antiplasmodial activity against P. falciparum FCR3 and D10 strains was tested in vitro. We used a modified fixed-ratio isobologram method to evaluate the activity of each of the 5 isolated compounds against the E64, an epoxide acting as a cysteine protease inhibitor. We used an in vitro Heme Polymerization Inhibition Assay (HPIA) to identify the ability of the isolated compounds to inhibit ?-hematin formation of P. falciparum. The 50% inhibitory concentration (IC50) values (±Standard Deviation (SD)) for the 5 isolated compounds against the P. falciparum FCR3 ranged from 2.1 (±0.1) to 808.8 (±26.8) ?g/ml and the IC50 values (±SD) against the P. falciparum D10 strain ranged from 55.9 (±28.2) to 1151.1 (±122.7) ?g/ml. The selectivity index was in the range of 0.1-66.2. Compounds 4 and 5 had greater antimalarial activity than the other compounds, with an antagonistic and an additive effect, respectively. The activity of Compound 4, interfering with hematin polymerization, and the additive interaction between Compound 5 and E64 corresponding to inhibition of protease enzymes could be possible action mechanisms of Compounds 4 and 5 suggesting them as potential antimalarial drug candidates.

Published

2020-06-11